| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.42B | +32.2% |
| Cost of Revenue | $1.08B | +38.6% |
| Gross Profit | $3.33B | +30.2% |
| R&D Expense | $512.4M | +20.8% |
| SG&A Expense | $169.0M | +17.8% |
| Operating Income | $969.6M | +49.1% |
| Interest Expense | $18.0M | +20.8% |
| Pre-tax Income | $955.5M | +52.1% |
| Income Tax | $30.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.68B | +27.6% |
| Accounts Receivable | $1.26B | +56.2% |
| Inventory | $264.6M | +50.5% |
| Current Assets | $3.81B | +5.8% |
| Total Assets | $6.23B | +5.2% |
| Current Liabilities | $3.08B | +32.8% |
| Long-term Debt | $990.4M | +0.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.73B | +15.4% |
| Investing Cash Flow | $763.9M | +157.6% |
| Financing Cash Flow | -$2.13B | -2672.8% |
| +118.4% |
| Net Income | $857.3M | +41.3% |
| EPS (Basic) | $1.08 | -71.0% |
| EPS (Diluted) | $1.06 | -70.8% |
| Total Liabilities |
| $6.51B |
| +27.1% |
| Stockholders' Equity | -$281.6M | -136.0% |